Pricing
Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (4)
Unverified
This company has no org chart yet
This company has no teams yet
This company has no offices yet